Naturalnano Inc (NNAN) 0.0262 $NNAN
NaturalNano Receives New Orders from Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products; Reports Record Sales for Q1
ACCESSWIRE - Wed Jun 24, 7:31AM CDT
ROCHESTER, NY / ACCESSWIRE / June 24, 2015 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today that it received new increased orders for its proprietary Halloysite Nanotubes (HNT) from Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. HNT is a key component and differentiator for a number of the Fiabila Product lines. The recent orders for HNT helped lift NNAN's Q1 sales for the current year to a record high of $115,085 and substantial increase vs Q1 2014. The Company reported total sales for all of 2014 were $193,606.
Cancer Cell Targeting Breakthrough Using NaturalNano's Halloysite Modified with Surfactants
ACCESSWIRE - Thu Apr 16, 9:00AM CDT
ROCHESTER, NY / ACCESSWIRE / April 16, 2015 / NaturalNano, Inc. (PINKSHEETS:NNAN) (www.naturalnano.com) announced today a new breakthrough for Cancer targeting using our NaturalNano Halloysite modified with surfactants.
NaturalNano Extends Its Long Term Commercial Relationship with Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products
ACCESSWIRE - Tue Feb 17, 9:46AM CST
ROCHESTER, NY / ACCESSWIRE / February 17, 2015 / NaturalNano, Inc. (OTCPK: NNAN) (www.naturalnano.com) announced today a three year extension of its long term relationship with Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. NNAN supplies Fiabila with its proprietary Halloysite Nanotubes (HNT) as a key component for a number of the Fiabila Product lines.
Ebola Stocks on the Rise as Death Toll Hits 5,000
ACCESSWIRE - Mon Dec 01, 11:28AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2014 / The death toll from the current Ebola outbreak has nearly hit 5,000 according to the World Health Organization (WHO). While the spread seems to be thankfully slowing, the Ebola stock phenomenon has now transitioned from fear-based speculative buying to concrete capital flows. Lakeland Industries (NASDAQ:LAKE), after surging on the mere news of Ebola and speculation that this would increase demand for the company's hazmat suits, is now surging again on the news that, indeed, the suits are starting to sell. Lakeland last week announced total orders of over one million Ebola suits from both government agencies and private sector customers. Sales will be accretive to earnings after January 31, 2015.
APT: 2.48 (-0.01), NLNK: 10.95 (-0.22), LAKE: 9.09 (+0.23), GSK: 44.16 (+0.12)
NaturalNano's ViralProtec Division Ships Ebola Personal Protective Equipment to Hospitals in North America
ACCESSWIRE - Mon Dec 01, 8:01AM CST
ROCHESTER, NY / ACCESSWIRE / December 1, 2014 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced that its ViralProtec Division (www.viralprotec.com) has successfully executed and shipped Personal Protective Equipment orders to multiple hospitals in North America.
NaturalNano Establishes ViralProtec Division to Supply Personal Protective Equipment for Caregivers in Fight Against Ebola and Other Infectious Diseases
Marketwired - Tue Oct 28, 7:55AM CDT
NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today the formation of its ViralProtec Division (www.viralprotec.com) to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.
NaturalNano Receives New Orders from Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products; Reports Record Sales for Q1
ACCESSWIRE - Wed Jun 24, 7:31AM CDT
ROCHESTER, NY / ACCESSWIRE / June 24, 2015 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today that it received new increased orders for its proprietary Halloysite Nanotubes (HNT) from Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. HNT is a key component and differentiator for a number of the Fiabila Product lines. The recent orders for HNT helped lift NNAN's Q1 sales for the current year to a record high of $115,085 and substantial increase vs Q1 2014. The Company reported total sales for all of 2014 were $193,606.
Cancer Cell Targeting Breakthrough Using NaturalNano's Halloysite Modified with Surfactants
ACCESSWIRE - Thu Apr 16, 9:00AM CDT
ROCHESTER, NY / ACCESSWIRE / April 16, 2015 / NaturalNano, Inc. (PINKSHEETS:NNAN) (www.naturalnano.com) announced today a new breakthrough for Cancer targeting using our NaturalNano Halloysite modified with surfactants.
NaturalNano Extends Its Long Term Commercial Relationship with Fiabila S.A. a World Leader in the Manufacture of Cosmetic Products
ACCESSWIRE - Tue Feb 17, 9:46AM CST
ROCHESTER, NY / ACCESSWIRE / February 17, 2015 / NaturalNano, Inc. (OTCPK: NNAN) (www.naturalnano.com) announced today a three year extension of its long term relationship with Fiabila S.A., a world leader in the manufacture of nail polish and nail care products. NNAN supplies Fiabila with its proprietary Halloysite Nanotubes (HNT) as a key component for a number of the Fiabila Product lines.
Ebola Stocks on the Rise as Death Toll Hits 5,000
ACCESSWIRE - Mon Dec 01, 11:28AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2014 / The death toll from the current Ebola outbreak has nearly hit 5,000 according to the World Health Organization (WHO). While the spread seems to be thankfully slowing, the Ebola stock phenomenon has now transitioned from fear-based speculative buying to concrete capital flows. Lakeland Industries (NASDAQ:LAKE), after surging on the mere news of Ebola and speculation that this would increase demand for the company's hazmat suits, is now surging again on the news that, indeed, the suits are starting to sell. Lakeland last week announced total orders of over one million Ebola suits from both government agencies and private sector customers. Sales will be accretive to earnings after January 31, 2015.
APT: 2.48 (-0.01), NLNK: 10.95 (-0.22), LAKE: 9.09 (+0.23), GSK: 44.16 (+0.12)
NaturalNano's ViralProtec Division Ships Ebola Personal Protective Equipment to Hospitals in North America
ACCESSWIRE - Mon Dec 01, 8:01AM CST
ROCHESTER, NY / ACCESSWIRE / December 1, 2014 / NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced that its ViralProtec Division (www.viralprotec.com) has successfully executed and shipped Personal Protective Equipment orders to multiple hospitals in North America.
NaturalNano Establishes ViralProtec Division to Supply Personal Protective Equipment for Caregivers in Fight Against Ebola and Other Infectious Diseases
Marketwired - Tue Oct 28, 7:55AM CDT
NaturalNano, Inc. (PINKSHEETS: NNAN) (www.naturalnano.com) announced today the formation of its ViralProtec Division (www.viralprotec.com) to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.
